Clinical Trial Update: Dosing and Effectiveness Study of Sorafenib and RAD001 in the Treatment of Patients With Advanced Kidney Cancer [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating dosing and effectiveness of sorafenib plus RAD001 in advanced kidney cancer has completed with results posted in 2014.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Kidney Cancer

Drugs mentioned

• RAD001 (everolimus)
• Sorafenib (Sorafenib)

Snippet

Sponsor: SCRI Development Innovations, LLC | Conditions: Kidney Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2014-03-26